Protagonist Therapeutics PTGX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's operating lease liabilities (current)?
- Protagonist Therapeutics (PTGX) reported operating lease liabilities (current) of $2.34M in Q1 2026.
- How has Protagonist Therapeutics's operating lease liabilities (current) changed year-over-year?
- Protagonist Therapeutics's operating lease liabilities (current) increased by 49.2% year-over-year, from $1.57M to $2.34M.
- What is the long-term trend for Protagonist Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's operating lease liabilities (current) has grown at a 9.4% compound annual growth rate (CAGR), from $1.46M to $2.28M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.